The Cancer Drugs Fund: Paving the Way for Earlier and More Sustainable Access to Promising New Drugs
In 2011, The Cancer Drugs Fund (CDF) was launched to help patients in England access cancer drugs that had been rejected by the NHS. As a result of financial struggles, the CDF faced a reform and partnered with NICE and pharmaceutical companies.
The partnership has led to earlier engagements from manufacturers and a shorter time-frame for drug acceptances from assessment stages to entry into the CDF, especially when comparing to other European market authorisation.
The CDF pathway allows patients access promising new treatments earlier than other major European markets.
Follow this link to read the full blog post – The Cancer Drugs Fund: Paving the Way for Earlier and More Sustainable Access to Promising New Drugs